Currently, there are no FDA approved medications for treating fragile X syndrome. That may soon change, thanks to a $11.5 million NIH grant awarded to UC Davis Medical Center. The new funding will allow researchers to test a new drug that is designed to improve language learning for children with fragile X syndrome. UC Davis is one of only two medical centers approved for the drug trail in the nation. Since UC Davis Medical Center is home to the renowned MIND Institute, which hosts the Fragile X Research and Treatment Center, it is a logical choice for the treatment study.Read More
Science Market Update
Tags: CA, California, Research Funding, Drug Development, research grant, UC Davis - Medical Center, Southwest Region, new research grant, UCD, drug evaluation, BioResearch Product Faire, Bioresearch Grant
UC Davis Professor Kit Lam has been awarded two separate federal grants to further his cancer research. The first grant is from the National Institute of Biomedical Imaging and Bioengineering. This 4-year, $2 million grant will fund research on the use of targeted nanotheraputics against oral cancer. The second grant is from the National Cancer Institute. This 3-year, $1.2 million research grant will be used to explore new technology for functional imaging in living cells.Read More
Two prominent researchers at UC Davis are under a microscope for their work in stem-cell biotechnology. The pair from University of California, Davis was awarded close to $4 million in funding to improve biotechnology intended for physicians studying stem cell treatments.
The two grant awards, of over $1.8 million each, were awarded to Laura Marcu and Kent Leach by the California Institute for Regenerative Medicine (CIRM) to continue developing technology that is used in stem cell treatments for vascular disease, bone and cartilage repair.Read More
This prestigious designation makes the MIND Institute one of only fifteen Intellectual and Developmental Disabilities Research Centers in the country. Transition into this program is made possible by a five-year $6.5 million NIH grant and gives the institute critical new resources that will accelerate its progress in neurodevelopment research.
Tags: University of California Davis Medical Center, Bioinformatics, neurodevelopmental disorders, assays, molecular biology imaging, biological analysis, immunoassays, environmental contaminants, Autism, UCDMC, Funding, Research, NIH, UC Davis, UCD, grant, drug evaluation, developmental disabilities
An historic collaboration between the University of California Davis and China's BGI, the world’s largest genomics organization, has dramatically increased the University's genome sequencing capabilities and promises to open up altogether new research opportunities in the life sciences community with genomic studies of plants, animals, humans and microbes. The new joint endeavor is called BGI@UC Davis and will benefit both UCD and China's first citizen-managed, non-profit research institution.
Tags: 2014, University of California Davis Medical Center, 2013, University of California Davis, New research facilities, Southwest, California, University of California, UCDMC, BioResearch Product Faire Event, Genomics, genomics research, Sacramento, Davis, Sacramento Campus, UCD
The Bionic Man has not arrived, and to our knowledge the military has not equipped any special agents with cyborg implants to boost their optical capabilities in the field. No, the news is both less and more exciting than those fantasy scenarios: people with end-stage age-related macular degeneration (AMD) now have the chance to see again. Surgeons and vision scientists at the University of California Davis Eye Center in Sacramento recently celebrated their first successful procedure with the new technology. The medical duo that performed the operation were Drs. Mark Mannis and Jennifer Li.
The word antibacterial is popping up on more and more household items as merchandisers find that consumers generally believe that chemicals designed to kill bacteria are a useful additive to a product and boost its appeal. Very often the chemical that's added is one called triclosan, and according to recently published research by a team of University of California Davis biomedical scientists, the common polychloro phenoxy phenol causes muscle impairment in animal and lab tissue models. Specifically, it limits the ability of the muscle to expand and contract. A beating heart is one example.
Tags: CA, University of California Davis, cardiovascular research, chemical research, cell biology, California, 2012, animal science, chemistry research, BioResearch Product Faire Event, Davis, Sacramento Campus, UCD